Exploring subungual onycholemmal cysts: A rare case report and comprehensive literature review
In this report, we describe a 54-year-old man with unilateral second right finger nail onychodystrophy and onycholysis for 1 year. He did not have any history of recent trauma, pain, or bleeding. It was completely resected by surgery. Nail biopsy can contribute to the early diagnosis of SOC and improvement of treatment outcomes. (Source: Clinical Case Reports)
Source: Clinical Case Reports - April 13, 2024 Category: General Medicine Authors: Toktam Safari Giv,
Mahdiyeh Movahedi,
Sahar Dadkhahfar,
Farsad Biglari,
Azadeh Rakhshan,
Ghazal Mardani,
Meisam Jafari Kafiabadi Tags: CASE REPORT Source Type: research
Onychopapilloma: a single medical center experience in Southern Taiwan
Conclusions: This study highlights that longitudinal erythronychia and leukonychia emerged as the predominant clinical presentations of onychopapilloma. Furthermore, our findings suggest that surgical excision appears to be an effective method for onychopapilloma.PMID:38417812 | DOI:10.1080/09546634.2024.2318353 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - February 28, 2024 Category: Dermatology Authors: Po-Ta Lai Yung-Wei Chang Shang-Hung Lin Source Type: research
Cross-sectional study of the prevalence of hyperextension of the first metatarsophalangeal joint and its relationship to onycholysis in women with hallux valgus
Hallux Valgus (HV) deformity is associated with misalignment in the sagittal plane that affects the first toe. However, the repercussions of the first toe hyperextension in HV have been scarcely considered. Th... (Source: BMC Musculoskeletal Disorders)
Source: BMC Musculoskeletal Disorders - February 5, 2024 Category: Orthopaedics Authors: Rosana Gim énez-López and Carlos Barrios-Pitarque Tags: Research Source Type: research
Nail Changes in a Patient With Cancer
A man in his 30s with adenoid cystic carcinoma of the lung presented with nail changes of several months ’ duration. Chemotherapy with docetaxel and cisplatin was initiated for tumor recurrence, and nail changes developed 5 months later. Skin examination revealed onycholysis, splinter hemorrhage, and subungual hyperkeratosis on the fingernails with Beau lines and melanonychia on the toenails (Figure) . There were no symptoms of peripheral neuropathy. Fungal culture yielded negative results. Chemotherapy-associated nail changes were diagnosed and the patient was treated with topical emollients. (Source: Mayo Clinic Proceedings)
Source: Mayo Clinic Proceedings - October 1, 2023 Category: Internal Medicine Authors: Po-Chien Wu, Jennifer Wu, Yi-Teng Hung Tags: Medical image Source Type: research
Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system
CONCLUSION: Gender differences existed in ADE signals related to Osimertinib. The higher risk of ADEs in male patients was lung diseases that seem more serious than those nail toxicities or skin problems that occurred in female patients. In order to ensure the safety of medication, we should be alert to the differences between different genders and take corresponding preventive measures to reduce the occurrence of serious ADEs.PMID:37515501 | DOI:10.1080/14740338.2023.2243220 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - July 29, 2023 Category: Drugs & Pharmacology Authors: Zhiping Li Wenbin Zou Jiao Yuan Yunxiang Zhong Zhiwen Fu Source Type: research
Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system
CONCLUSION: Gender differences existed in ADE signals related to Osimertinib. The higher risk of ADEs in male patients were lung diseases that seem more serious than those nail toxicities or skin problems occurred in the female patients. In order to ensure the safety of medication, we should be alert to the differences between different genders and take corresponding preventive measures to reduce the occurrence of serious ADEs.PMID:37515501 | DOI:10.1080/14740338.2023.2243220 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - July 29, 2023 Category: Drugs & Pharmacology Authors: Zhiping Li Wenbin Zou Jiao Yuan Yunxiang Zhong Zhiwen Fu Source Type: research
